feedburner
Enter your email address:

Delivered by FeedBurner

Choose Your Stocks


ASIAPHARM ACHIEVES 27.9% REVENUE GROWTH TO RMB 651.0 MILLION DESPITE CHALLENGING OPERATING CONDITIONS (27 Feb 09)

Labels:

  • Revenue: +29.7% (4Q08), +27.9% (FY08)
  • Net Profit: +48.6% (4Q08), +6.8% (FY08)
  • Press Release: Increase in revenue due to higher sales of pharmaceutical drugs; principally attributable to contributions from proprietary drugs including Lipusu, Nuosen,Lutingnuo, CMNa and fresh contributions from Hypocol
  • Profit before tax grew 27.6% to RMB 83.7 million in line with revenue growth and increase in share of associates’ profits
  • Outlook: In view of the global economic downturn, the Group expects a more challenging environment for the next financial year.
  • However, with the recent PRC government’s healthcare reforms to increase healthcare expenditure in PRC, and together with its strong product base, the Group believes that it is in a strong position to face this competitive market.
FINANCIAL RECORDS

Revenue (RMB '000)

FY 1Q 2Q 3Q 4Q Total
2008 124,556 163,199 176,477 186,744 650,976
2007 106,752 127,815 130,477 143,936 508,980
2006 76,567 76,512 78,128 77,087 308,294
2005 70,775 92,117 84,719 96,757 344,368
2004 58,803 93,074 69,112 94,411 315,400
-----------------------------------------------------------
Earnings (RMB '000)

FY 1Q 2Q 3Q 4Q Total
2008 20,020 18,355 17,538 6,176 62,089
2007 21,763 16,353 15,860 (11,648) 59,539
2006 20,490 20,652 19,987 22,562 83,691
2005 15,558 24,467 19,999 29,596 89,620
2004 9,592 15,616 13,435 33,193 71,837
-----------------------------------------------------------
Dividends

FY Interim Final Special (USD)
2008 NA NA NA
2007 NA 0.004 NA
2006 NA 0.005 NA
2005 NA 0.005 NA
2004 NA 0.004 NA
-----------------------------------------------------------
Bonus / Rights / Stock Split

Date Type Details
NA
-----------------------------------------------------------
Share Data (RMB)

NAV = $1.668
EPS = $0.126 (12M FY08)
No of Shares = 492,764,900
-----------------------------------------------------------

ANALYSTS' TARGET PRICES

Broker Recommendation Target Price Date
NA



0 Comments:

Post a Comment

Subscribe to: Post Comments (Atom)